Log In
Print
BCIQ
Print
Print this Print this
 

8H9 mAb

  Manage Alerts
Collapse Summary General Information
Company United Therapeutics Corp.
Description8H9 mAb with specificity for B7-H3 antigen
Molecular Target B7-H3 (CD276)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationBrain cancer
Indication DetailsTreat metastatic brain cancer
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today